Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its ...

Roche Holding AG has rapidly developed a research-use only molecular PCR test to detect the rare Ebola Bundibugyo virus, to ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

This webinar explores the key differences between qPCR and digital PCR, highlighting where each technology excels and ...

Molbio Diagnostics is validating a portable Ebola PCR test with WHO-backed partners in the DRC and Uganda. The effort aims to ...

TIB MOLBIOL developed the test using its "rapid response" library, with 15,000 designs and 3,000 controls.

Allied Market Research published a report titled, "Food Safety Testing Market by Type (Pathogen, Genetically Modified ...

Molbio Diagnostics deploys decentralised molecular testing solution amid ongoing Ebola outbreak: Our Bureau, Bengaluru Friday, June 5, 2026, 11:40 Hrs [IST] Molbio Diagnostics has ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the launch of FoundationOne®MRD, a molecular residual disease (MRD) test. 1 This launch follows the ...

The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...

NIMS Hyderabad has launched Telangana’s first government-sector Next Generation Sequencing cancer testing facility.

Watchmaker Genomics has expanded its molecular diagnostics portfolio with the launch of Stellar RT qPCR and qPCR Kits, designed for assay developers working across PCR and isothermal modalities.